These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

514 related articles for article (PubMed ID: 2089771)

  • 21. [Improvement of the quality of life for hemodialysis patients using recombinant human erythropoietin].
    Schaefer RM
    Krankenpfl J; 1988; 26(7-8):317-20. PubMed ID: 3419139
    [No Abstract]   [Full Text] [Related]  

  • 22. [The treatment of anemia of hemodialysis patients using recombinant human erythropoietin: comparison between intravenous and subcutaneous administration].
    Zehnder C; Blumberg A
    Schweiz Med Wochenschr; 1990 Feb; 120(7):217-20. PubMed ID: 2309110
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Countermeasure for patients with anemia due to hemodialysis].
    Suzuki M
    Nihon Naika Gakkai Zasshi; 1995 Oct; 84(10):1663-7. PubMed ID: 8537721
    [No Abstract]   [Full Text] [Related]  

  • 24. [Treatment of anemia in chronically dialyzed patients].
    Moynot A
    Nephrologie; 1998; 19(3):125-7. PubMed ID: 9633055
    [No Abstract]   [Full Text] [Related]  

  • 25. Effect of recombinant human erythropoietin on iron balance in maintenance hemodialysis: theoretical considerations, clinical experience and consequences.
    Grützmacher P; Tsobanelis T; Roth P; Werner E; Vlachojannis J; Kaltwasser J; Kurz P; Scheuermann EH; Schoeppe W
    Clin Nephrol; 1992; 38 Suppl 1():S92-7. PubMed ID: 1295714
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The recovery of erythropoiesis after the short-term Recormon treatment of renal anemia].
    Nikolaev AIu; Klepikov PV; Lashutin SV
    Ter Arkh; 1992; 64(6):90-1. PubMed ID: 1440349
    [No Abstract]   [Full Text] [Related]  

  • 27. Anemia and erythropoietin in hemodialysis and continuous ambulatory peritoneal dialysis.
    Korbet SM
    Kidney Int Suppl; 1993 Feb; 40():S111-9. PubMed ID: 8445832
    [No Abstract]   [Full Text] [Related]  

  • 28. [Recent findings on the pathogenesis and therapy of anemia in chronic kidney failure].
    Moccia F; Morra L; Gurreri G
    Recenti Prog Med; 1992 Oct; 83(10):572-6. PubMed ID: 1462041
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Treatment of anemia in chronic hemodialysis patients with recombinant human erythropoietin: long-term results in 15 patients].
    Jacquot C; Berthelot JM; Chiappini-Judith D; Ferragu-Haguet M; Lefebvre A; Masselot JP; Moynot A; Frydman MO; Peterlongo F
    Nephrologie; 1990; 11(1):11-6. PubMed ID: 2374641
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Is the index of response to erythropoietin (IRE) a good marker of adequate dialysis?].
    Pérez-García R; Rodríguez-Benítez P; Villaverde MT; Valderrábano F
    Nefrologia; 2001; 21(6):606-7. PubMed ID: 11881433
    [No Abstract]   [Full Text] [Related]  

  • 31. Excessive level of parathyroid hormone may induce the reduction of recombinant human erythropoietin effect on renal anemia.
    Fujita Y; Inoue S; Horiguchi S; Kuki A
    Miner Electrolyte Metab; 1995; 21(1-3):50-4. PubMed ID: 7565462
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Management of iron deficiency in renal anemia: guidelines for the optimal therapeutic approach in erythropoietin-treated patients.
    Drüeke TB; Bárány P; Cazzola M; Eschbach JW; Grützmacher P; Kaltwasser JP; Macdougall IC; Pippard MJ; Shaldon S; van Wyck D
    Clin Nephrol; 1997 Jul; 48(1):1-8. PubMed ID: 9247771
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Blood rheology in hemodialysis patients treated with recombinant human erythropoietin.
    Brunner R; Pollok M; Heidel M; Müller R; Degenhardt S; Baldamus CA
    Contrib Nephrol; 1989; 76():306-12; discussion 312-4. PubMed ID: 2582784
    [No Abstract]   [Full Text] [Related]  

  • 34. Correction of the anemia of end-stage renal disease with recombinant human erythropoietin.
    N Engl J Med; 1987 Jul; 317(4):249-51. PubMed ID: 3600716
    [No Abstract]   [Full Text] [Related]  

  • 35. Effect of recombinant human erythropoietin on the anemia of chronic renal failure.
    Urabe A; Takaku F; Mizoguchi H; Kubo K; Ota K; Shimizu N; Tanaka K; Mimura N; Nihei H; Koshikawa S
    Int J Cell Cloning; 1988 May; 6(3):179-91. PubMed ID: 3397592
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Erythropoietin treatment improves quality of life in hemodialysis patients.
    Bárány P; Pettersson E; Bergström J
    Scand J Urol Nephrol Suppl; 1990; 131():55-60. PubMed ID: 2075471
    [TBL] [Abstract][Full Text] [Related]  

  • 37. N-acetylcysteine for the management of anemia and oxidative stress in hemodialysis patients.
    Hsu SP; Chiang CK; Yang SY; Chien CT
    Nephron Clin Pract; 2010; 116(3):c207-16. PubMed ID: 20606481
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Recombinant human erythropoietin: 18 months of continuous use in substitution hemodialysis].
    Canaud B; Polito-Bouloux C; Rivory JP; Donnadieu P; Taib J; Florence P; Mion C
    Nephrologie; 1990; 11(1):5-10. PubMed ID: 2374643
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Erythropoietin in renal anemia].
    Peña Amaro MP; García López J; Camacho Romera M
    Rev Enferm; 1992 Mar; 15(163):67-70. PubMed ID: 1565973
    [No Abstract]   [Full Text] [Related]  

  • 40. Erythropoietin use in peritoneal dialysis patients.
    Zimmerman SW; Johnson CA
    Am J Kidney Dis; 1991 Oct; 18(4 Suppl 1):38-41. PubMed ID: 1928078
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.